KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Other Working Capital Changes: 2011-2025

Historic Other Working Capital Changes for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Sep 2025 value amounting to $11.1 million.

  • Supernus Pharmaceuticals' Other Working Capital Changes rose 535.71% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.1 million, marking a year-over-year increase of 2214.91%. This contributed to the annual value of $19.4 million for FY2024, which is 5694.01% up from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Other Working Capital Changes stood at $11.1 million for Q3 2025, which was up 345.40% from $2.5 million recorded in Q2 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Other Working Capital Changes peaked at $28.2 million during Q2 2023, and registered a low of -$20.4 million during Q3 2023.
  • Moreover, its 3-year median value for Other Working Capital Changes was $1.8 million (2024), whereas its average is $2.4 million.
  • Over the last 5 years, Supernus Pharmaceuticals' Other Working Capital Changes had its largest YoY gain of 3,603.48% in 2023, and its largest YoY loss of 1,556.33% in 2023.
  • Over the past 5 years, Supernus Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$4.7 million in 2021, then skyrocketed by 73.52% to -$9.2 million in 2022, then grew by 15.22% to -$7.8 million in 2023, then surged by 238.52% to $10.8 million in 2024, then spiked by 535.71% to $11.1 million in 2025.
  • Its Other Working Capital Changes was $11.1 million in Q3 2025, compared to $2.5 million in Q2 2025 and -$7.4 million in Q1 2025.